Literature DB >> 17003027

The-2548G/A polymorphism in the human leptin gene promoter region is associated with plasma free leptin levels; interaction with adiposity and gender in healthy subjects.

Nikos Yiannakouris1, Lambros Melistas, Mary Yannakoulia, Keisha Mungal, Christos S Mantzoros.   

Abstract

A common -2548G/A promoter variant of the human leptin gene has recently been shown to be associated with variations in circulating leptin levels but available data are still conflicting. The aim of this study was to explore potential associations between the -2548G/A polymorphism and adiposity-related variables, plasma total leptin levels, as well as soluble leptin receptor (sOB-R) levels and free leptin in a group of healthy Greek subjects. One hundred eighteen consecutively enrolled subjects [62 females, 56 males; mean age+/-SD: 17.7+/-1.8 years; body mass index (BMI) range: 15.4-35.9 kg/m2] were genotyped for the -2548G/A polymorphism and their BMI, fat free mass, % fat mass, fasting plasma total leptin and sOB-R levels were determined. The ratio leptin/sOB-R was used as an index of free leptin. No significant differences in genotype and allele frequencies of the -2548G/A polymorphism were detected between normal weight and overweight subjects, and no association was found between this polymorphism and BMI, fat mass or plasma total leptin levels. However, the -2548G/A polymorphism was found to be associated with circulating free leptin levels in a gender specific manner. More specifically, compared to carriers of the -2548G allele, female subjects with the A/A genotype had higher age and fat mass adjusted mean (+/-SE) plasma concentrations of sOB-R (32.9+/-7.2 vs. 25.6+/-3.8 ng/ml, P=0.05), and significantly lower (approx. 50%) leptin/sOB-R values (0.74+/-0.25 vs. 1.42+/-0.13, P=0.02). Furthermore, multiple regression analysis revealed that, after adjustment to fat mass, the -2548G/A genotype and gender are significantly associated with free leptin index in the entire study sample. Similar regression models revealed a significant interaction of gender and genotype when considered in addition to fat mass, or fat mass and genotype when considered in addition to gender, as predictors of free leptin index. In conclusion, the common -2548G/A promoter variant of the human leptin gene is associated with plasma free leptin levels through an interaction with adiposity and gender in healthy subjects.

Entities:  

Year:  2003        PMID: 17003027     DOI: 10.14310/horm.2002.11104

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  14 in total

1.  Polymorphisms in LEP and NPY genes modify the response to soluble fibre Plantago ovata husk intake on cardiovascular risk biomarkers.

Authors:  Anna Crescenti; Rosa Solà; Rosa M Valls; Anna Anguera; Lluís Arola
Journal:  Genes Nutr       Date:  2012-06-06       Impact factor: 5.523

2.  Gonadotropin response to clomiphene and plasma leptin levels in weight recovered but amenorrhoeic patients with anorexia nervosa.

Authors:  M Djurovic; S Pekic; M Petakov; S Damjanovic; M Doknic; C Dieguez; F F Casanueva; V Popovic
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

3.  Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer.

Authors:  Christos Yapijakis; Michael Kechagiadakis; Emeka Nkenke; Zoe Serefoglou; Dimitrios Avgoustidis; Antonis Vylliotis; Despina Perrea; Friedrich W Neukam; Efstratios Patsouris; Eleftherios Vairaktaris
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

4.  Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.

Authors:  Hai-Ling Liu; Yang-Gen Lin; Jing Wu; Hong Sun; Zhi-Cheng Gong; Ping-Cheng Hu; Ji-Ye Yin; Wei Zhang; Dan Wang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Eur J Clin Pharmacol       Date:  2008-04-26       Impact factor: 2.953

5.  Adipokine genes and prostate cancer risk.

Authors:  Steven C Moore; Michael F Leitzmann; Demetrius Albanes; Stephanie J Weinstein; Kirk Snyder; Jarmo Virtamo; Jiyoung Ahn; Susan T Mayne; Herbert Yu; Ulrike Peters; Marc J Gunter
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

6.  Drug-naive patients with schizophrenia have metabolic disorders that are not associated with polymorphisms in the LEP (-2548G/A) and 5-HTR2C (-759C/T) genes.

Authors:  Jinhong Chen; Liwen Tan; Zhou Long; Lifeng Wang; Li Hu; Dong Yang
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

7.  Leptin, leptin gene and leptin receptor gene polymorphism in heart failure with preserved ejection fraction.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Rasha H Mohamed; Heba F Pasha
Journal:  Heart Vessels       Date:  2011-05-17       Impact factor: 2.037

8.  -2548G>A LEP Polymorphism Is Positively Associated with Increased Leptin and Glucose Levels in Obese Saudi Patients Irrespective of Blood Pressure Status.

Authors:  Essa M Sabi; Lotfi S Bin Dahman; Abdul Khader Mohammed; Khalid M Sumaily; Nasser M Al-Daghri
Journal:  Medicina (Kaunas)       Date:  2022-02-24       Impact factor: 2.430

9.  Effect of three common SNPs in 5'-flanking region of LEP and ADIPOQ genes on their expression in Polish obese children and adolescents.

Authors:  J Cieslak; M Bartz; M Stachowiak; B Skowronska; K A Majewska; J Harasymczuk; W Stankiewicz; P Fichna; M Switonski
Journal:  Mol Biol Rep       Date:  2011-07-14       Impact factor: 2.316

10.  Leptin and Leptin receptor polymorphisms, plasma Leptin levels and obesity in Tunisian volunteers.

Authors:  Zayani Nesrine; Hamdouni Haithem; Boumaiza Imen; Neffati Fadoua; Omezzine Asma; Najjar Mohamed Fadhel; Bouslama Ali
Journal:  Int J Exp Pathol       Date:  2018-06-11       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.